Osteoprotegerin and breast cancer risk by hormone receptor subtype: a nested case-control study in the EPIC cohort. (2017)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.7617
Publication URI: https://www.repository.cam.ac.uk/handle/1810/262354
Type: Journal Article/Review